Elmiron Lawsuits: IC Drug Linked to Eye Damage
Elmiron lawsuits allege that the drug maker did not disclose the link between Elmiron use and serious vision damage and failed to warn patients about this risk.
In June 2020, the drug maker updated the product labeling to inform users of potential vision problems, though this warning comes too late for those already suffering from eye damage.
If you or a loved one took Elmiron and later suffered from vision issues, you may be entitled to compensation. To learn if you may qualify, get a FREE legal consultation from Sokolove Law.
Elmiron’s Potentially Permanent Side Effects
Elmiron, a prescription drug used to treat bladder pain and discomfort associated with interstitial cystitis (IC), has come under fire for its link to serious eye damage. Elmiron users across the United States claim that the drug may cause many vision issues.
Elmiron may be linked to the following diseases:
- Macular degeneration
- Pigmentary maculopathy
- Retinal maculopathy
Other Elmiron side effects may include:
- Blurred vision
- Difficulty reading
- Distorted vision
- Eye pain
- Issues adjusting to darkness
- Vision disturbances
- Vision loss
What Is Elmiron Used For?
Approved by the U.S. Food and Drug Administration (FDA) in 1996, pentosan polysulfate sodium (Elmiron) is the only FDA-approved oral medication designed to treat bladder pain and discomfort associated with interstitial cystitis (IC).
IC, also known as “painful bladder syndrome,” is a chronic bladder condition with no known cure.
If you or a loved one used this IC drug and have since developed one of the vision impairments listed above, you may be eligible to file an Elmiron lawsuit.
For more information, contact Sokolove Law today. Our Case Managers are available 24/7 to answer your questions and provide support.
